# BioDockify-Formulate™ - Complete Training Plan
## 7-Model Federated AI Stack for ANDA Readiness

**Environment**: Google Colab Pro + NVIDIA L4 GPU (24 GB VRAM)  
**Timeline**: 24 weeks (6 months)  
**Cost**: $13/month (Colab Pro) + AWS Free Tier  
**Architecture**: Federated Modular AI (NOT monolithic)

---

## System Architecture

```
ONE JOB PER MODEL = TRANSPARENCY + PHARMA TRUST

BioDockify-Formulate™ = 7 Independent AI Models
├─ Model 1: API Representation (ChemBERTa + GNN)
├─ Model 2: Pre-Formulation Risk (XGBoost)
├─ Model 3: Excipient Selection (GNN + Ranking)
├─ Model 4: Dissolution Prediction (LSTM/TCN)
├─ Model 5: Stability & Shelf-Life (Survival ML)
├─ Model 6: QbD/Regulatory Documents (Fine-tuned LLM)
├─ Model 7: ANDA Readiness Engine (MCDA Ensemble)
└─ Backbone: Knowledge Graph (Neo4j)
```

---

## Phase 1: Foundation Models (Weeks 1-8)

### Week 1-2: Model 1A - ChemBERTa for API Representation

**Objective**: Convert API structure → formulation-relevant molecular features

**Training Setup**
```python
Model: DeepChem/ChemBERTa-77M-MTR
Task: Multi-task fine-tuning
  - Solubility class (4 classes: high/medium/low/very low)
  - pKa (regression)
  - LogP (regression)
  - Hygroscopicity (3 classes: low/medium/high)
```

**Dataset Requirements**
- **Size**: 10,000+ APIs with diverse properties
- **Sources**: DrugBank, ChEMBL, PubChem, literature
- **Labels**: Solubility, pKa, LogP, hygroscopicity

**Training Configuration**
- Batch Size: 32
- Learning Rate: 2e-5
- Epochs: 10
- Loss: Weighted multi-task (0.3 solubility + 0.2 pKa + 0.2 LogP + 0.3 hygroscopicity)

**Expected Output**: 768-dim embeddings + property predictions

---

### Week 3-4: Model 1B - GNN for Solid-State Behavior

**Objective**: Predict polymorphism risk and crystal packing

**Architecture**
```python
Type: Graph Attention Network (GAT)
Layers: 3x GATConv (8 attention heads)
Node Features: Atomic number, hybridization, aromaticity
Output: 256-dim solid-state features
```

**Dataset Requirements**
- **Size**: 5,000+ crystal structures
- **Sources**: Cambridge Structural Database (CSD)
- **Labels**: Polymorphism risk, melting point, crystal system

**Expected Output**: Structure-aware API fingerprints

---

### Week 5-6: Model 2 - Pre-Formulation Risk Prediction

**Objective**: BCS classification, polymorphism risk, formulation difficulty

**Architecture**
```python
Ensemble:
  - XGBoost (BCS classification)
  - LightGBM (Polymorphism risk)
  - Random Forest (Formulation difficulty)
```

**Feature Engineering**
- Molecular weight, LogP, pKa from ChemBERTa
- H-bond donors/acceptors
- TPSA (topological polar surface area)
- Rotatable bonds
- Solubility category

**Dataset Requirements**
- **Size**: 8,000+ APIs with BCS labels
- **Sources**: Formulation databases, FDA Orange Book

**Validation Metrics**
- BCS classification accuracy: >80%
- Polymorphism risk AUC: >0.75
- Formulation difficulty RMSE: <2.0

---

### Week 7-8: Model 3 - Excipient Selection & Compatibility

**Objective**: Rank excipients by API-excipient compatibility

**Architecture**
```python
Type: Learning-to-Rank (LambdaMART)
Framework: LightGBM Ranker
Features:
  - API-excipient physicochemical compatibility
  - pH compatibility
  - Solubility match score
  - Hydrogen bonding potential
  - Historical success rate
```

**Excipient Database**
- Cellulose derivatives (MCC, HPMC, HPC)
- Lactose, maltose
- Magnesium stearate
- Calcium phosphate
- Starch, talc, silica

**Dataset Requirements**
- **Size**: 2,000+ formulation case studies
- **Sources**: Patent databases, formulation journals

**Expected Output**: Ranked excipient list for each API

---

## Phase 2: Time-Dependent Models (Weeks 9-16)

### Week 9-10: Model 4A - LSTM Dissolution Prediction

**Objective**: Predict drug release profile over time

**Architecture**
```python
Type: LSTM (Long Short-Term Memory)
Layers: 2x LSTM (128 units) + Dense
Input: API properties + excipient composition + dosage form
Output: Dissolution % at t = [5, 10, 15, 30, 45, 60] min
```

**Dataset Requirements**
- **Size**: 1,500+ dissolution profiles
- **Sources**: FDA dissolution database, in-house data

**Training Configuration**
- Sequence Length: 6 time points
- Loss: MSE (time-series)
- Optimizer: Adam (lr=1e-3)
- Epochs: 50

---

### Week 11-12: Model 4B - TCN Dissolution (Alternative)

**Objective**: Temporal convolutional network for complex release patterns

**Architecture**
```python
Type: Temporal Convolutional Network (TCN)
Advantage: Better for long-range dependencies than LSTM
Use Case: Extended-release formulations
```

---

### Week 13-14: Model 5A - Survival Model for Stability

**Objective**: Predict degradation risk over shelf-life

**Architecture**
```python
Type: Cox Proportional Hazards Model
Framework: scikit-survival
Features:
  - Temperature
  - Humidity
  - Light exposure
  - API stability class
  - Excipient interactions
```

**Dataset Requirements**
- **Size**: 1,000+ stability studies (ICH guidelines)
- **Labels**: Time to 10% degradation

---

### Week 15-16: Model 5B - DeepSurv Shelf-Life Prediction

**Objective**: Deep learning for shelf-life estimation

**Architecture**
```python
Type: DeepSurv (Deep Survival Analysis)
Network: MLP with survival loss
Output: Probability of stability at t = [6, 12, 24, 36] months
```

**Validation**: Concordance index (C-index) >0.75

---

## Phase 3: Regulatory & Decision (Weeks 17-24)

### Week 17-18: Model 6A - LLM Fine-Tuning for QbD

**Objective**: Generate Quality by Design (QbD) documents

**Architecture**
```python
Base Model: GPT-3.5 or Llama 2 (7B)
Fine-tuning: LoRA (Low-Rank Adaptation)
Task: Generate QTPP, CQA, CPP sections
```

**Dataset Requirements**
- **Size**: 500+ FDA QbD submissions
- **Format**: QTPP templates, CQA specifications

---

### Week 19-20: Model 6B - Rule Engine + Templates

**Objective**: Ensure regulatory compliance via rule-based validation

**Components**
- ICH Q8/Q9/Q10 compliance checker
- FDA ANDA Module 3 template generator
- Risk assessment matrix (FMEA)

---

### Week 21-22: Model 7 - ANDA Readiness Ensemble

**Objective**: Multi-Criteria Decision Analysis (MCDA) for go/no-go decision

**Architecture**
```python
Type: Ensemble Decision System
Inputs:
  - BCS class (Model 2)
  - Dissolution similarity (Model 4)
  - Stability score (Model 5)
  - QbD completeness (Model 6)
Weights: Expert-defined (AHP or TOPSIS)
Output: ANDA Readiness Score (0-100)
```

**Decision Thresholds**
- 80-100: High confidence (Go)
- 60-79: Moderate (Conditional go)
- 0-59: High risk (No-go)

---

### Week 23: Integration Testing

**Objective**: Test all 7 models as a federated system

**Pipeline**
```
Input: API SMILES + Target Dosage Form
  ↓
Model 1: API Representation
  ↓
Model 2: Pre-Formulation Risk
  ↓
Model 3: Excipient Selection
  ↓
Model 4: Dissolution Prediction
  ↓
Model 5: Stability Projection
  ↓
Model 6: QbD Documentation
  ↓
Model 7: ANDA Readiness Score
  ↓
Output: Comprehensive Formulation Report
```

---

### Week 24: AWS Production Deployment

**Deployment Strategy**
- **API Gateway**: RESTful endpoints
- **Lambda Functions**: Serverless model inference (3 GB memory)
- **S3**: Model storage (~2 GB total)
- **DynamoDB**: Prediction history
- **Neo4j (Aura)**: Knowledge graph backbone

**Estimated Costs**
- Lambda: ~$5/month (1M requests)
- S3: ~$1/month
- Neo4j Aura Free Tier: $0

---

## Validation Benchmarks

### Model 1 (ChemBERTa)
- Solubility accuracy: >75%
- pKa RMSE: <1.5

### Model 2 (XGBoost Risk)
- BCS classification: >80%
- Polymorphism AUC: >0.75

### Model 3 (Excipient Ranking)
- NDCG@10: >0.80
- Top-3 accuracy: >70%

### Model 4 (LSTM Dissolution)
- Profile similarity (f2): >60
- Time-point RMSE: <10%

### Model 5 (DeepSurv Stability)
- C-index: >0.75
- 12-month prediction error: <15%

### Model 6 (LLM QbD)
- BLEU score: >0.60
- Regulatory compliance: Manual review

### Model 7 (ANDA Ensemble)
- Decision accuracy: >85% (expert validation)

---

## Hardware Requirements

### Google Colab Pro
- **GPU**: NVIDIA L4 (24 GB)
- **Runtime**: 4-6 hours/day
- **Cost**: $13/month

### AWS Deployment
- **Lambda**: 3 GB memory per function
- **S3**: 2 GB model storage
- **Inference Time**: <1s per API

---

## Expected Deliverables

1. **7 Trained Models** (saved to Google Drive)
2. **Inference API** (RESTful endpoints)
3. **Web Dashboard** (React frontend)
4. **Validation Report** (benchmarks + case studies)
5. **User Documentation** (API guide + tutorials)

---

## Next Steps After Training

1. **Clinical Phase Integration**: Link to Phase I/II data
2. **Continuous Learning**: Update models with new formulation data
3. **Pharma Partnerships**: Validate on proprietary datasets
4. **Regulatory Certification**: FDA pre-submission meeting
